We downgrade our rating from BUY to OUTPERFORM while trimming our target price by 6.0% as we lower our 2020F and 2021-2024F recurring NPAT-MI by 24.6% and ~17% on average due to slow progress of M&C projects, which outweighs the impact of reducing our dis